Insider · CIK 0002078090
Kristin England
Files at STLN (Oncology Institute, Inc.). First filing -, latest -.
In brief
Kristin England files SEC Form 4 as officer at STLN (Oncology Institute, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kristin England has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | STLN Oncology Institute, Inc. | AGrant or award Common Stock | +55,743 | $0.00 | $0 | 153,780 | Apr 1, 2026 |
| Jul 22, 2025 | STLN Oncology Institute, Inc. | AGrant or award Common Stock | +98,037 | $0.00 | $0 | 98,037 | Jul 24, 2025 |
Questions about Kristin England
Answered from the filings on this page, as of the latest one.
Is Kristin England buying or selling?
Kristin England has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kristin England's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kristin England has 0.
Where does Kristin England file Form 4?
Kristin England has filed Form 4 at STLN (Oncology Institute, Inc.) as Chief Administrative Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.